 AbbVie NYSE:ABBV had its price objective raised by investment analysts at Mizuho from 101.00 to 110.00 in a research note issued to investors on Monday, The Fly reports. The firm currently has a buy rating on the stock. Mizuhos target price would suggest a potential upside of 14.43 from the companys previous close. Several other ... 